 Heres a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks Biotech Stocks Hitting 52-week highs on March 3 Acceleron Pharma Inc NASDAQ: XLRN BioMarin Pharmaceutical Inc. NASDAQ: BMRN Fate Therapeutics Inc NASDAQ: FATE reacted to its fourth-quarter results Forty Seven Inc NASDAQ: FTSV IGM Biosciences Inc NASDAQ: IGMS Inovio Pharmaceuticals Inc NASDAQ: INO announced an accelerated timeline for COVID-19 vaccine development Repro-Med Systems, Inc. NASDAQ: KRMD SpringWorks Therapeutics Inc NASDAQ: SWTX Zynex Inc. NASDAQ: ZYXI Down In The Dumps Biotech Stocks Hitting 52-week lows on March 3 ADDEX THERAPEUTADR NASDAQ: ADXN Akorn, Inc. NASDAQ: AKRX Aldeyra Therapeutics Inc NASDAQ: ALDX ANI Pharmaceuticals Inc NASDAQ: ANIP Evolus Inc NASDAQ: EOLS EXACT Sciences Corporation NASDAQ: EXAS HTG Molecular Diagnostics Inc NASDAQ: HTGM Midatech Pharma PLC-ADR NASDAQ: MTP began trading on a reverse split adjusted basis Mylan NV NASDAQ: MYL Neuronetics Inc NASDAQ: STIM announced its fourth-quarter results Passage Bio Inc NASDAQ: PASG IPOed last week STRATA Skin Sciences Inc NASDAQ: SSKN SurModics, Inc. NASDAQ: SRDX Tetraphase Pharmaceuticals Inc NASDAQ: TTPH TransMedics Group Inc NASDAQ: TMDX reported its fourth-quarter results VIVUS, Inc. NASDAQ: VVUS Xeris Pharmaceuticals Inc NASDAQ: XERS See Also: Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates Stocks In Focus Takeda To Develop COVID-19 Treatments Takeda Pharmaceutical Co Ltd NYSE: TAK said it is initiating the development of an anti-SARS-CoV-2 polyclonal hyperimmune globulin to treat high-risk individuals with the viral infection. 